The Comparative Efficacy of the Zio Patch vs Implantable Loop Recorder in Atrial Fibrillation
Withdrawn before enrolling · Not applicable
Conditions studied: Atrial Fibrillation
In brief
The aim of our study is to investigate if LTCM's are superior to implantable loop recorders in detecting atrial fibrillation after pulmonary vein isolation. This study will provide insights on a possible alternative for detection of arrhythmia.
Key facts
- Study ID
- NCT02954380
- Run by
- University of Florida
- People needed
- 0
- Starts
- 2016-11-01
- Expected to finish
- 2018-06-01
- Last updated by the study team
- 2017-03-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients with a diagnosis of paroxysmal or persistent atrial fibrillation documented on electrocardiography
- Patients must already have a Medtronic LINQ ILR as standard of care already implanted as standard of care
- Patients must be available for at least 7 but maximum of 14 days after patch application
- Patients must be greater than or equal to 18 years old.
You may not qualify if…
- Patients with a history of permanent atrial fibrillation
- Patients with an implanted pacemaker or implantable cardioverter defibrillator
- Patients with cognitive delay and or dementia
- Patients unable to give Consent.
- Patients with adhesive allergy
Where it is running
- University of Florida — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.